Patents by Inventor Jay J. Armstrong

Jay J. Armstrong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements
    Patent number: 5622963
    Abstract: This invention relates to a technique for treating a mammal with rapamycin which comprises removal of blood from the patient, treatment of the formed blood elements with rapamycin which binds rapidly and reversibly with erythrocytes, and returning the treated blood cells to the circulatory system of the patient for the treatment of any of the diseases, syndromes, conditions, or immune responses which respond to treatment with rapamycin. Alternatively, blood to be treated with rapamycin can be obtained from a hematologically compatible donor mammal.
    Type: Grant
    Filed: April 18, 1995
    Date of Patent: April 22, 1997
    Assignee: American Home Products Corporation
    Inventors: Jay J. Armstrong, Surendra N. Sehgal
  • Method of treating anemia
    Patent number: 5561138
    Abstract: This invention provides a method of treating immune related anemia in a mammal which comprises administering rapamycin to said mammal orally, parenterally, intravascularly, intranasally, intrabronchially, transdermally, rectally.
    Type: Grant
    Filed: December 13, 1994
    Date of Patent: October 1, 1996
    Assignee: American Home Products Corporation
    Inventor: Jay J. Armstrong
  • Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements
    Patent number: 5547959
    Abstract: This invention relates to a technique for treating a mammal with rapamycin which comprises removal of blood from the patient, treatment of the formed blood elements with rapamycin which binds rapidly and reversibly with erythrocytes, and returning the treated blood cells to the circulatory system of the patient for the treatment of any of the diseases, syndromes, conditions, or immune responses which respond to treatment with rapamycin. Alternatively, blood to be treated with rapamycin can be obtained from a hematologically compatible donor mammal.
    Type: Grant
    Filed: April 18, 1995
    Date of Patent: August 20, 1996
    Assignee: American Home Products Corporation
    Inventors: Jay J. Armstrong, Surendra N. Sehgal
  • Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements
    Patent number: 5543418
    Abstract: This invention relates to a technique for treating a mammal with rapamycin which comprises removal of blood from the patient, treatment of the formed blood elements with rapamycin which binds rapidly and reversibly with erythrocytes, and returning the treated blood cells to the circulatory system of the patient for the treatment of any of the diseases, syndromes, conditions, or immune responses which respond to treatment with rapamycin. Alternatively, blood to be treated with rapamycin can be obtained from a hematologically compatible donor mammal.
    Type: Grant
    Filed: April 18, 1995
    Date of Patent: August 6, 1996
    Assignee: American Home Products Corporation
    Inventors: Jay J. Armstrong, Surendra N. Sehgal
  • Method of treating cardiac inflammatory disease
    Patent number: 5496832
    Abstract: This invention provides a method of treating cardiac inflammatory disease which comprises administering rapamycin to said mammal orally, parenterally, intravascularly, intranasally, intrabronchially, transdermally, or rectally.
    Type: Grant
    Filed: March 9, 1995
    Date of Patent: March 5, 1996
    Assignee: American Home Products Corporation
    Inventor: Jay J. Armstrong
  • Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements
    Patent number: 5482945
    Abstract: This invention relates to a technique for treating a mammal with rapamycin which comprises removal of blood from the patient, treatment of the formed blood elements with rapamycin which binds rapidly and reversibly with erythrocytes, and returning the treated blood cells to the circulatory system of the patient for the treatment of any of the diseases, syndromes, conditions, or immune responses which respond to treatment with rapamycin. Alternatively, blood to be treated with rapamycin can be obtained from a hematologically compatible donor mammal.
    Type: Grant
    Filed: December 22, 1992
    Date of Patent: January 9, 1996
    Assignee: American Home Products Corporation
    Inventors: Jay J. Armstrong, Surendra N. Sehgal